Pathways to Prevention (Protocol TN-01)

Summary

This study will help us learn more about how type 1 diabetes occurs as well as help us to identify people who may be eligible for prevention trials through screening. By ongoing monitoring, we will compare people with and without auto-antibodies to help us better understand differences over time.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 2 to 45

Accepts healthy participants: Yes

Inclusion criteria:

- 2 to 45 years old and have a brother, sister, child, or parent with type 1 diabetes.
- 2 to 20 years old and have a cousin, aunt, uncle, niece, nephew, half-brother, half-sister, or grandparent with type 1 diabetes.
- Individuals (age 2 years - 45 years) who have diabetes related autoantibodies found though external screening

Exclusion criteria:

Individuals with Type 1 diabetes

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Heidi.Virtanen@ahs.ca 403-955-8866

Principal investigator:

Carol Huang

Clinical trial:

No

REB-ID:

REB14-2465